Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

Atkore Inc (NYSE: ATKR), which manufactures electrical products for commercial, industrial, data center, telecommunications and solar applications, said on Tuesday that David Johnson had resigned as Vice President, Chief Financial Officer and Chief Accounting Officer, effective August 9th.

In connection with Johnson’s departure from the firm, John Deitzer has been appointed as Vice President and Chief Financial Officer, while James Alvey – as Chief Accounting Officer.

Most recently, Deitzer served as Vice President of Finance – Electrical business unit at Atkore.

He joined the firm in 2019, assuming the role of Vice President of Investor Relations.

Before that, John Deitzer was four years at Alcoa Corporation, assuming Investor Relations and Management Consulting & Strategy roles.

“On behalf of Atkore, I thank David for his numerous contributions during the past six years,” Bill Waltz, President and Chief Executive Officer of Atkore Inc, said in a press release.

“Under his leadership, Atkore has created a balanced capital deployment model enabling acquisitions, internal investments, stock repurchases and quarterly dividends. Adhering to this disciplined financial management in combination with our standard organizational leadership succession planning will certainly provide for a smooth transition of responsibilities.”

Stock Performance

The shares of Atkore Inc (ATKR) closed 0.30% ($0.43) higher at $145.00 in New York on Tuesday, as they extended the gain from the previous market session.

The company’s total market cap now stands at $5.282 billion.

The shares of Atkore Inc (ATKR) went up 41.07% in 2023, compared with a 10.99% gain for the benchmark index, NYSE Composite (NYA).

The company’s shares have retreated 9.37% so far this year.

TradingPedia.com is a financial media specialized in providing daily news and education covering Forex, equities and commodities. Our academies for traders cover Forex, Price Action and Social Trading.

Related News

  • Forex Market: USD/CAD daily trading outlookForex Market: USD/CAD daily trading outlook Yesterday’s trade saw USD/CAD within the range of 1.3280-1.3326. The pair closed at 1.3296, ticking up 0.07% on a daily basis. It has been the first gain in the past three trading days. The daily low was a higher-low test of the low from […]
  • US Leading Indicators Index up, exceeding forecastsUS Leading Indicators Index up, exceeding forecasts Leading Indicators Index in United States, which was published earlier today, rose by a greater than expected rate during April.The index showed an increase in value to 0.6%, while expectations were for a 0.2% rise. During the previous […]
  • Lufthansa shares plummet as biggest shareholder opposes €9 billion bailoutLufthansa shares plummet as biggest shareholder opposes €9 billion bailout Shares in Lufthansa dropped 5.7% in Monday trading as the biggest shareholder in the company disagreed with the terms of a €9 billion ($10 billion) bailout. If the rescue plan fails, this will put the biggest airline in Europe in serious […]
  • Forex Market: USD/CAD daily trading forecastForex Market: USD/CAD daily trading forecast Yesterday’s trade saw USD/CAD within the range of 1.2388-1.2535. The pair closed at 1.2507, gaining 0.60% on a daily basis.At 9:13 GMT today USD/CAD was down 0.30% for the day to trade at 1.2478, which is also the current daily […]
  • ING Signals CAD Strength as USD/CAD Tests 1.35ING Signals CAD Strength as USD/CAD Tests 1.35 Key Moments ING notes the Canadian Dollar has been the top-performing G10 currency since the conflict began, aided by resilient equity markets and Canada's energy-exporter profile. Markets are currently pricing in a Bank of […]
  • Sanofi stock closes low despite $13 billion deal on Regeneron sharesSanofi stock closes low despite $13 billion deal on Regeneron shares Sanofi’s shares closed lower in Tuesday trading despite the recent deal for selling its shares in the U.S. biotechnology company Regeneron. Sanofi will earn about $13 billion after selling a huge part of its 20.6% stake in Regeneron. Despite […]